Immuno-Oncology Crosstalk and Metabolism

1 Cancer Metabolism and Aggressive Tumor Behaviour.- 2 Immune Cell Metabolism and Function.- 3 Cancer Cell Metabolism Effecting Immune function.- 4 Immune Cell Metabolites as Fuel for Cancer Cells.- 5 Immuno-Onco metabolism and Resistance to Therapy.- 6 Targeting Immuno-Onco metaolism in Cancers.- 7 Timing of the major metabolic switches in immune cell activation and differentiation during cancer development.

Dr. Muzafar Ahmad Macha is working as an Assistant Professor and a Ramanlingaswami Fellow at the Watson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology (IUST), India. He completed his Ph.D. from All India Institute of Medical Sciences, AIIMS, New Delhi. He did his postdoctoral training from the Department of Biochemistry and Molecular Biology (BMB), University of Nebraska Medical center (UNMC), USA. Dr. Macha has published more than 45 peer-reviewed articles in journals of high repute and authored or co-authored numerous books and book chapters. He has been conferred with two prestigious Ramalingaswami & Ramanujan fellowships from Govt. of India. He is a member of many international scientific societies and organizations importantly American Association of Cancer Research (AACR), International Agency for Research on Cancer (IARC) and American Society of Clinical Oncology (ASCO). He is an Associate Editor of Frontiers of Oncology, Gastrointestinal Cancer Section and editorial board member and reviewer of many international journals.

Dr. Ajaz Ahmad Bhat is a research scientist at the Dept. of Molecular and Metabolic Imaging Laboratory, Sidra Medicine, Qatar. He completed his Ph.D. from All India Institute of Medical Sciences, AIIMS, New Delhi. During postdoctoral training at Vanderbilt University Medical School (VUMS), he worked on the pathobiological importance of tight junction proteins (Claudins) and bile acid-induced APE1/Ref1 in the pathogenesis of Colorectal and Esophageal Cancers, respectively. He has published in several journals of high repute, including Nature Communications, GUT, Oncogene, Cancer Research, and Molecular Cancer. Recently, he was awarded as an outstanding researcher for the years 2018 and 2019 from Sidra Medicine. He is an active member of many Immunology and Cancer societies and is serving in the editorial board review of many peer reviewed journals.Dr. Nissar Ahmad Wani